Sign in
CompletedNo phase

Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy

Key facts

Who runs it
The University of Texas Health Science Center, Houston
Where
Houston, United StatesSee the site
Trial code
Status
Completed
People taking part
1,628 people enrolled
Started
7 Mar 2023
Ended
16 Sept 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Group 1: one-hour GCT
  • Group 2: CGM placement
Record updated
4 December 2025

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • 24-30 weeks gestation undergoing GDM screening

Who cannot take part

  • History of bariatric surgery
  • History of allergic reaction to any of CGM metals or adhesives in contact with the skin
  • Known diagnosis of Type I and II DM
  • Major fetal anomalies
  • Unwilling to use CGM for GDM screening
  • Incarcerated subjects

Where in United States

  • The University of Texas Health Science Center at HoustonHouston, United States

About the trial

What the trial wants to find out

The purpose of this study is to evaluate whether Continuous glucose monitoring (CGM) for diagnosis of gestational diabetes mellitus (GDM) improves maternal and neonatal outcomes related to GDM and to evaluate whether CGM for GDM diagnosis reduces the health system costs for mother-infant dyads compared to usual care

The 2 groups in the trial

  • one-hour Glucose tolerance test (GCT)Existing treatment, for comparison

    Treatment: Group 1: one-hour GCT

  • CGM screeningTreatment being tested

    Treatment: Group 2: CGM placement

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy:A Comparative Effectiveness Randomized Control Trial (PRECISE)
Publications
Record updated
4 December 2025